Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 2002 Jun;110(Suppl 3):349–353. doi: 10.1289/ehp.02110s3349

Goitrogenic and estrogenic activity of soy isoflavones.

Daniel R Doerge 1, Daniel M Sheehan 1
PMCID: PMC1241182  PMID: 12060828

Abstract

Soy is known to produce estrogenic isoflavones. Here, we briefly review the evidence for binding of isoflavones to the estrogen receptor, in vivo estrogenicity and developmental toxicity, and estrogen developmental carcinogenesis in rats. Genistein, the major soy isoflavone, also has a frank estrogenic effect in women. We then focus on evidence from animal and human studies suggesting a link between soy consumption and goiter, an activity independent of estrogenicity. Iodine deficiency greatly increases soy antithyroid effects, whereas iodine supplementation is protective. Thus, soy effects on the thyroid involve the critical relationship between iodine status and thyroid function. In rats consuming genistein-fortified diets, genistein was measured in the thyroid at levels that produced dose-dependent and significant inactivation of rat and human thyroid peroxidase (TPO) in vitro. Furthermore, rat TPO activity was dose-dependently reduced by up to 80%. Although these effects are clear and reproducible, other measures of thyroid function in vivo (serum levels of triiodothyronine, thyroxine, and thyroid-stimulating hormone; thyroid weight; and thyroid histopathology) were all normal. Additional factors appear necessary for soy to cause overt thyroid toxicity. These clearly include iodine deficiency but may also include additional soy components, other defects of hormone synthesis, or additional goitrogenic dietary factors. Although safety testing of natural products, including soy products, is not required, the possibility that widely consumed soy products may cause harm in the human population via either or both estrogenic and goitrogenic activities is of concern. Rigorous, high-quality experimental and human research into soy toxicity is the best way to address these concerns. Similar studies in wildlife populations are also appropriate.

Full Text

The Full Text of this article is available as a PDF (155.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adlercreutz H., Fotsis T., Watanabe S., Lampe J., Wähälä K., Mäkelä T., Hase T. Determination of lignans and isoflavonoids in plasma by isotope dilution gas chromatography-mass spectrometry. Cancer Detect Prev. 1994;18(4):259–271. [PubMed] [Google Scholar]
  2. Canaris G. J., Manowitz N. R., Mayor G., Ridgway E. C. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000 Feb 28;160(4):526–534. doi: 10.1001/archinte.160.4.526. [DOI] [PubMed] [Google Scholar]
  3. Cassidy A., Bingham S., Setchell K. D. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr. 1994 Sep;60(3):333–340. doi: 10.1093/ajcn/60.3.333. [DOI] [PubMed] [Google Scholar]
  4. Chang H. C., Churchwell M. I., Delclos K. B., Newbold R. R., Doerge D. R. Mass spectrometric determination of Genistein tissue distribution in diet-exposed Sprague-Dawley rats. J Nutr. 2000 Aug;130(8):1963–1970. doi: 10.1093/jn/130.8.1963. [DOI] [PubMed] [Google Scholar]
  5. Chang H. C., Doerge D. R. Dietary genistein inactivates rat thyroid peroxidase in vivo without an apparent hypothyroid effect. Toxicol Appl Pharmacol. 2000 Nov 1;168(3):244–252. doi: 10.1006/taap.2000.9019. [DOI] [PubMed] [Google Scholar]
  6. Chorazy P. A., Himelhoch S., Hopwood N. J., Greger N. G., Postellon D. C. Persistent hypothyroidism in an infant receiving a soy formula: case report and review of the literature. Pediatrics. 1995 Jul;96(1 Pt 1):148–150. [PubMed] [Google Scholar]
  7. Dansette P. M., Bonierbale E., Minoletti C., Beaune P. H., Pessayre D., Mansuy D. Drug-induced immunotoxicity. Eur J Drug Metab Pharmacokinet. 1998 Oct-Dec;23(4):443–451. doi: 10.1007/BF03189993. [DOI] [PubMed] [Google Scholar]
  8. Delclos K. B., Bucci T. J., Lomax L. G., Latendresse J. R., Warbritton A., Weis C. C., Newbold R. R. Effects of dietary genistein exposure during development on male and female CD (Sprague-Dawley) rats. Reprod Toxicol. 2001 Nov-Dec;15(6):647–663. doi: 10.1016/s0890-6238(01)00177-0. [DOI] [PubMed] [Google Scholar]
  9. Divi R. L., Chang H. C., Doerge D. R. Anti-thyroid isoflavones from soybean: isolation, characterization, and mechanisms of action. Biochem Pharmacol. 1997 Nov 15;54(10):1087–1096. doi: 10.1016/s0006-2952(97)00301-8. [DOI] [PubMed] [Google Scholar]
  10. Divi R. L., Doerge D. R. Inhibition of thyroid peroxidase by dietary flavonoids. Chem Res Toxicol. 1996 Jan-Feb;9(1):16–23. doi: 10.1021/tx950076m. [DOI] [PubMed] [Google Scholar]
  11. Divi R. L., Doerge D. R. Mechanism-based inactivation of lactoperoxidase and thyroid peroxidase by resorcinol derivatives. Biochemistry. 1994 Aug 16;33(32):9668–9674. doi: 10.1021/bi00198a036. [DOI] [PubMed] [Google Scholar]
  12. Doerge D. R., Chang H. C., Churchwell M. I., Holder C. L. Analysis of soy isoflavone conjugation in vitro and in human blood using liquid chromatography-mass spectrometry. Drug Metab Dispos. 2000 Mar;28(3):298–307. [PubMed] [Google Scholar]
  13. Doerge D. R., Chang H. C., Divi R. L., Churchwell M. I. Mechanism for inhibition of thyroid peroxidase by leucomalachite green. Chem Res Toxicol. 1998 Sep;11(9):1098–1104. doi: 10.1021/tx970226o. [DOI] [PubMed] [Google Scholar]
  14. Doerge D. R., Churchwell M. I., Delclos K. B. On-line sample preparation using restricted-access media in the analysis of the soy isoflavones, genistein and daidzein, in rat serum using liquid chromatography electrospray mass spectrometry. Rapid Commun Mass Spectrom. 2000;14(8):673–678. doi: 10.1002/(SICI)1097-0231(20000430)14:8<673::AID-RCM935>3.0.CO;2-F. [DOI] [PubMed] [Google Scholar]
  15. Doerge D. R., Decker C. J. Inhibition of peroxidase-catalyzed reactions by arylamines: mechanism for the anti-thyroid action of sulfamethazine. Chem Res Toxicol. 1994 Mar-Apr;7(2):164–169. doi: 10.1021/tx00038a008. [DOI] [PubMed] [Google Scholar]
  16. Doerge D. R., Divi R. L., Deck J., Taurog A. Mechanism for the anti-thyroid action of minocycline. Chem Res Toxicol. 1997 Jan;10(1):49–58. doi: 10.1021/tx960150g. [DOI] [PubMed] [Google Scholar]
  17. Doerge D. R., Takazawa R. S. Mechanism of thyroid peroxidase inhibition by ethylenethiourea. Chem Res Toxicol. 1990 Mar-Apr;3(2):98–101. doi: 10.1021/tx00014a003. [DOI] [PubMed] [Google Scholar]
  18. Duncan A. M., Merz B. E., Xu X., Nagel T. C., Phipps W. R., Kurzer M. S. Soy isoflavones exert modest hormonal effects in premenopausal women. J Clin Endocrinol Metab. 1999 Jan;84(1):192–197. doi: 10.1210/jcem.84.1.5387. [DOI] [PubMed] [Google Scholar]
  19. Fang H., Tong W., Shi L. M., Blair R., Perkins R., Branham W., Hass B. S., Xie Q., Dial S. L., Moland C. L. Structure-activity relationships for a large diverse set of natural, synthetic, and environmental estrogens. Chem Res Toxicol. 2001 Mar;14(3):280–294. doi: 10.1021/tx000208y. [DOI] [PubMed] [Google Scholar]
  20. Fort P., Moses N., Fasano M., Goldberg T., Lifshitz F. Breast and soy-formula feedings in early infancy and the prevalence of autoimmune thyroid disease in children. J Am Coll Nutr. 1990 Apr;9(2):164–167. doi: 10.1080/07315724.1990.10720366. [DOI] [PubMed] [Google Scholar]
  21. HYDOVITZ J. D. Occurrence of goiter in an infant on a soy diet. N Engl J Med. 1960 Feb 18;262:351–353. doi: 10.1056/NEJM196002182620707. [DOI] [PubMed] [Google Scholar]
  22. Holder C. L., Churchwell M. I., Doerge D. R. Quantification of soy isoflavones, genistein and daidzein, and conjugates in rat blood using LC/ES-MS. J Agric Food Chem. 1999 Sep;47(9):3764–3770. doi: 10.1021/jf9902651. [DOI] [PubMed] [Google Scholar]
  23. Ikeda T., Nishikawa A., Imazawa T., Kimura S., Hirose M. Dramatic synergism between excess soybean intake and iodine deficiency on the development of rat thyroid hyperplasia. Carcinogenesis. 2000 Apr;21(4):707–713. doi: 10.1093/carcin/21.4.707. [DOI] [PubMed] [Google Scholar]
  24. Ishizuki Y., Hirooka Y., Murata Y., Togashi K. [The effects on the thyroid gland of soybeans administered experimentally in healthy subjects]. Nihon Naibunpi Gakkai Zasshi. 1991 May 20;67(5):622–629. doi: 10.1507/endocrine1927.67.5_622. [DOI] [PubMed] [Google Scholar]
  25. Jabbar M. A., Larrea J., Shaw R. A. Abnormal thyroid function tests in infants with congenital hypothyroidism: the influence of soy-based formula. J Am Coll Nutr. 1997 Jun;16(3):280–282. doi: 10.1080/07315724.1997.10718686. [DOI] [PubMed] [Google Scholar]
  26. Kay T., Kimura M., Nishing K., Itokawa Y. Soyabean, goitre, and prevention. J Trop Pediatr. 1988 Jun;34(3):110–113. doi: 10.1093/tropej/34.3.110. [DOI] [PubMed] [Google Scholar]
  27. Kimura S., Suwa J., Ito M., Sato H. Development of malignant goiter by defatted soybean with iodine-free diet in rats. Gan. 1976 Oct;67(5):763–765. [PubMed] [Google Scholar]
  28. King R. A., Broadbent J. L., Head R. J. Absorption and excretion of the soy isoflavone genistein in rats. J Nutr. 1996 Jan;126(1):176–182. doi: 10.1093/jn/126.1.176. [DOI] [PubMed] [Google Scholar]
  29. Konijn A. M., Edelstein S., Guggenheim K. Separation of a thyroid-active fraction from unheated soya bean flour. J Sci Food Agric. 1972 May;23(5):549–555. doi: 10.1002/jsfa.2740230502. [DOI] [PubMed] [Google Scholar]
  30. Labib M., Gama R., Wright J., Marks V., Robins D. Dietary maladvice as a cause of hypothyroidism and short stature. BMJ. 1989 Jan 28;298(6668):232–233. doi: 10.1136/bmj.298.6668.232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Medlock K. L., Branham W. S., Sheehan D. M. Effects of coumestrol and equol on the developing reproductive tract of the rat. Proc Soc Exp Biol Med. 1995 Jan;208(1):67–71. doi: 10.3181/00379727-208-43833. [DOI] [PubMed] [Google Scholar]
  32. NORDSIEK F. W. Effects of added casein on goitrogenic action of different dietary levels of soybeans. Proc Soc Exp Biol Med. 1962 Jul;110:417–420. doi: 10.3181/00379727-110-27535. [DOI] [PubMed] [Google Scholar]
  33. Newbold R. R., Banks E. P., Bullock B., Jefferson W. N. Uterine adenocarcinoma in mice treated neonatally with genistein. Cancer Res. 2001 Jun 1;61(11):4325–4328. [PubMed] [Google Scholar]
  34. PINCHERA A., MACGILLIVRAY M. H., CRAWFORD J. D., FREEMAN A. G. THYROID REFRACTORINESS IN AN ATHYREOTIC CRETIN FED SOYBEAN FORMULA. N Engl J Med. 1965 Jul 8;273:83–87. doi: 10.1056/NEJM196507082730205. [DOI] [PubMed] [Google Scholar]
  35. Poirier L. A., Doerge D. R., Gaylor D. W., Miller M. A., Lorentzen R. J., Casciano D. A., Kadlubar F. F., Schwetz B. A. An FDA review of sulfamethazine toxicity. Regul Toxicol Pharmacol. 1999 Dec;30(3):217–222. doi: 10.1006/rtph.1999.1348. [DOI] [PubMed] [Google Scholar]
  36. RIPP J. A. Soybean-induced goiter. Am J Dis Child. 1961 Jul;102:106–109. doi: 10.1001/archpedi.1961.02080010108017. [DOI] [PubMed] [Google Scholar]
  37. Setchell K. D., Zimmer-Nechemias L., Cai J., Heubi J. E. Exposure of infants to phyto-oestrogens from soy-based infant formula. Lancet. 1997 Jul 5;350(9070):23–27. doi: 10.1016/S0140-6736(96)09480-9. [DOI] [PubMed] [Google Scholar]
  38. Sfakianos J., Coward L., Kirk M., Barnes S. Intestinal uptake and biliary excretion of the isoflavone genistein in rats. J Nutr. 1997 Jul;127(7):1260–1268. doi: 10.1093/jn/127.7.1260. [DOI] [PubMed] [Google Scholar]
  39. Sheehan D. M. Herbal medicines, phytoestrogens and toxicity: risk:benefit considerations. Proc Soc Exp Biol Med. 1998 Mar;217(3):379–385. doi: 10.3181/00379727-217-44248. [DOI] [PubMed] [Google Scholar]
  40. Sheehan D. M. Isoflavone content of breast milk and soy formulas: benefits and risks. Clin Chem. 1997 May;43(5):850–852. [PubMed] [Google Scholar]
  41. Son H. Y., Nishikawa A., Ikeda T., Imazawa T., Kimura S., Hirose M. Lack of effect of soy isoflavone on thyroid hyperplasia in rats receiving an iodine-deficient diet. Jpn J Cancer Res. 2001 Feb;92(2):103–108. doi: 10.1111/j.1349-7006.2001.tb01071.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Thigpen J. E., Setchell K. D., Ahlmark K. B., Locklear J., Spahr T., Caviness G. F., Goelz M. F., Haseman J. K., Newbold R. R., Forsythe D. B. Phytoestrogen content of purified, open- and closed-formula laboratory animal diets. Lab Anim Sci. 1999 Oct;49(5):530–536. [PubMed] [Google Scholar]
  43. VAN WYK J. J., ARNOLD M. B., WYNN J., PEPPER F. The effects of a soybean product on thyroid function in humans. Pediatrics. 1959 Nov;24:752–760. [PubMed] [Google Scholar]
  44. Watanabe S., Terashima K., Sato Y., Arai S., Eboshida A. Effects of isoflavone supplement on healthy women. Biofactors. 2000;12(1-4):233–241. doi: 10.1002/biof.5520120136. [DOI] [PubMed] [Google Scholar]
  45. Woeber K. A. Subclinical thyroid dysfunction. Arch Intern Med. 1997 May 26;157(10):1065–1068. [PubMed] [Google Scholar]
  46. Zhang Y., Song T. T., Cunnick J. E., Murphy P. A., Hendrich S. Daidzein and genistein glucuronides in vitro are weakly estrogenic and activate human natural killer cells at nutritionally relevant concentrations. J Nutr. 1999 Feb;129(2):399–405. doi: 10.1093/jn/129.2.399. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES